Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Durie

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
British Journal of Haematology|October 29, 2020
Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect<sup>®</sup> MM RegistryRafat Abonour, Robert M Rifkin, Cristina Gasparetto, et al.
Blood|September 19, 2015
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myelomaJatin J Shah, Edward A Stadtmauer, Rafat Abonour, et al.
Blood Cancer Journal|November 11, 2024
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM RegistrySikander Ailawadhi, Hans C Lee, James Omel, et al.
Blood Cancer Journal|July 24, 2021
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect<sup>®</sup> MM RegistryHans C Lee, Sikander Ailawadhi, Cristina J Gasparetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myelomaDavid C Johnson, Sophie L Corthals, Brian A Walker, et al.
Leukemia|September 3, 2010
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working GroupE Terpos, M A Dimopoulos, O Sezer, et al.
Blood Cancer Journal|November 25, 2018
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research ProjectSaad Z Usmani, Antje Hoering, Michele Cavo, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 30, 2021
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM RegistryCristina Gasparetto, Sundar Jagannath, Robert M Rifkin, et al.
Cancer|July 25, 2020
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysisSikander Ailawadhi, Sundar Jagannath, Hans C Lee, et al.
Practical Radiation Oncology|November 20, 2023
Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM RegistryLeslie Ballas, Sikander Ailawadhi, Mohit Narang, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
British Journal of Haematology|October 29, 2020
Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect<sup>®</sup> MM RegistryRafat Abonour, Robert M Rifkin, Cristina Gasparetto, et al.
Blood|September 19, 2015
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myelomaJatin J Shah, Edward A Stadtmauer, Rafat Abonour, et al.
Blood Cancer Journal|November 11, 2024
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM RegistrySikander Ailawadhi, Hans C Lee, James Omel, et al.
Blood Cancer Journal|July 24, 2021
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect<sup>®</sup> MM RegistryHans C Lee, Sikander Ailawadhi, Cristina J Gasparetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myelomaDavid C Johnson, Sophie L Corthals, Brian A Walker, et al.
Leukemia|September 3, 2010
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working GroupE Terpos, M A Dimopoulos, O Sezer, et al.
Blood Cancer Journal|November 25, 2018
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research ProjectSaad Z Usmani, Antje Hoering, Michele Cavo, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 30, 2021
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM RegistryCristina Gasparetto, Sundar Jagannath, Robert M Rifkin, et al.
Cancer|July 25, 2020
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysisSikander Ailawadhi, Sundar Jagannath, Hans C Lee, et al.
Practical Radiation Oncology|November 20, 2023
Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM RegistryLeslie Ballas, Sikander Ailawadhi, Mohit Narang, et al.
Pageof 15